Natalizumab-induced thrombocytopenia: A case report
Curr J Neurol
.
2022 Jan 5;21(1):64-65.
doi: 10.18502/cjn.v21i1.9363.
Authors
Amirreza Azimi
1
,
Zohreh Abna
1
,
Fereshteh Ghadiri
1
,
Farzad Mehrabi
1
Affiliation
1
Multiple Sclerosis Research Center, Tehran University of Medical Sciences, Tehran, Iran.
PMID:
38011417
PMCID:
PMC9527860
DOI:
10.18502/cjn.v21i1.9363
No abstract available
Keywords:
Drug; Immune Thrombocytopenia; Multiple Sclerosis; Natalizumab; Therapeutics.